SynthesisFrontiers in aging neuroscience2024

Comparative the efficacy and safety of Gosuranemab, Semorinemab, Tilavonemab, and Zagotenemab in patients with Alzheimer's disease: a systematic review and network meta-analysis of randomized controlled trials.

Wenting Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.